Healthway Medical Corporation Limited reported unaudited group earnings results for the second quarter and six months ended June 30, 2018. For the quarter, the company reported revenue of SGD 28,644,000 against SGD 25,461,000 a year ago. Profit before income tax was SGD 16,000 against loss of SGD 2,470,000 a year ago. Profit attributable to shareholders was SGD 78,000 against loss of SGD 2,624,000 or 0.09 cents per share a year ago. Net cash used in operating activities was SGD 631,000 against SGD 8,120,000 a year ago. Addition to property, plant and equipment was SGD 63,000 against SGD 601,000 a year ago. Addition to intangible assets was SGD 153,000.

For the six months, the company reported revenue of SGD 57,304,000 against SGD 48,625,000 a year ago. Profit before income tax was SGD 115,000 against loss of SGD 2,716,000 a year ago. Profit attributable to shareholders was SGD 194,000 against loss of SGD 3,128,000 or 0.11 cents per share a year ago. Net cash used in operating activities was SGD 2,698,000 against SGD 12,300,000 a year ago. Addition to property, plant and equipment was SGD 191,000 against SGD 889,000 last year. Addition to intangible assets was SGD 153,000.

For the quarter, the company reported Property, plant and equipment written off of SGD 117,000.